UK markets close in 7 hours 23 minutes
  • FTSE 100

    5,889.99
    +5.34 (+0.09%)
     
  • FTSE 250

    17,830.61
    -35.47 (-0.20%)
     
  • AIM

    974.73
    -0.38 (-0.04%)
     
  • GBP/EUR

    1.0994
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2948
    +0.0007 (+0.06%)
     
  • BTC-GBP

    9,043.03
    +503.24 (+5.89%)
     
  • CMC Crypto 200

    238.13
    +4.96 (+2.13%)
     
  • S&P 500

    3,426.92
    -56.42 (-1.62%)
     
  • DOW

    28,195.42
    -410.88 (-1.44%)
     
  • CRUDE OIL

    40.73
    -0.10 (-0.24%)
     
  • GOLD FUTURES

    1,903.30
    -8.40 (-0.44%)
     
  • NIKKEI 225

    23,567.04
    -104.09 (-0.44%)
     
  • HANG SENG

    24,557.00
    +14.74 (+0.06%)
     
  • DAX

    12,822.34
    -32.32 (-0.25%)
     
  • CAC 40

    4,941.91
    -0.71 (-0.01%)
     

Global Brain Tumor Diagnosis and Treatment Industry

ReportLinker
·26-min read

Global Brain Tumor Diagnosis and Treatment Market to Reach $887. 5 Million by 2027. Amid the COVID-19 crisis, the global market for Brain Tumor Diagnosis and Treatment estimated at US$537. 5 Million in the year 2020, is projected to reach a revised size of US$887.

New York, Sept. 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Brain Tumor Diagnosis and Treatment Industry" - https://www.reportlinker.com/p05960584/?utm_source=GNW
5 Million by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Primary Brain Tumor, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$587.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Secondary Brain Tumor segment is readjusted to a revised 7.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $145.3 Million, While China is Forecast to Grow at 11.2% CAGR

The Brain Tumor Diagnosis and Treatment market in the U.S. is estimated at US$145.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$197 Million by the year 2027 trailing a CAGR of 11.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.We bring years of research experience to this 7th edition of our report. The 381-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • AstraZeneca PLC

  • Carestream Health, Inc.

  • GE Healthcare

  • Hitachi Medical Corporation

  • Merck & Co., Inc.

  • Pfizer, Inc.

  • Philips Healthcare

  • Shimadzu Corporation

  • Siemens Healthineers

  • Toshiba Medical Systems Corporation




Read the full report: https://www.reportlinker.com/p05960584/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Brain Tumor Diagnosis and Treatment Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027

Table 2: World Historic Review for Brain Tumor Diagnosis and
Treatment by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019

Table 3: World 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Primary Brain
Tumor by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 5: World Historic Review for Primary Brain Tumor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 6: World 15-Year Perspective for Primary Brain Tumor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Secondary Brain
Tumor by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 8: World Historic Review for Secondary Brain Tumor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 9: World 15-Year Perspective for Secondary Brain Tumor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for CT Scan by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 11: World Historic Review for CT Scan by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 12: World 15-Year Perspective for CT Scan by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for MRI by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 14: World Historic Review for MRI by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 15: World 15-Year Perspective for MRI by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for PET-CT Scan by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 17: World Historic Review for PET-CT Scan by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 18: World 15-Year Perspective for PET-CT Scan by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other Diagnosis
Types by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 20: World Historic Review for Other Diagnosis Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 21: World 15-Year Perspective for Other Diagnosis Types
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Surgery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 23: World Historic Review for Surgery by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 24: World 15-Year Perspective for Surgery by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Radiation Therapy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 26: World Historic Review for Radiation Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 27: World 15-Year Perspective for Radiation Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Targeted Therapy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 29: World Historic Review for Targeted Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 30: World 15-Year Perspective for Targeted Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Chemotherapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 32: World Historic Review for Chemotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 33: World 15-Year Perspective for Chemotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Immunotherapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 35: World Historic Review for Immunotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 36: World 15-Year Perspective for Immunotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Brain Tumor Diagnosis and Treatment Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 37: USA Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 38: USA Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 39: USA 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 41: USA Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 42: USA 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 44: USA Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 45: USA 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 47: Canada Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 48: Canada 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 50: Canada Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 51: Canada 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 53: Canada Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 54: Canada 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

JAPAN
Table 55: Japan Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 56: Japan Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 57: Japan 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 59: Japan Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 60: Japan 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 62: Japan Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 63: Japan 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

CHINA
Table 64: China Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 65: China Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 66: China 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 67: China Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 68: China Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 69: China 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 70: China Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 71: China Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 72: China 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Brain Tumor Diagnosis and Treatment Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 73: Europe Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 74: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 75: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 77: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 78: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 80: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 81: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 83: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 84: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

FRANCE
Table 85: France Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 86: France Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 87: France 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 88: France Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 89: France Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 90: France 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 91: France Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 92: France Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 93: France 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

GERMANY
Table 94: Germany Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 95: Germany Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 96: Germany 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 98: Germany Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 99: Germany 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 100: Germany Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 101: Germany Historic Review for Brain Tumor Diagnosis
and Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 102: Germany 15-Year Perspective for Brain Tumor
Diagnosis and Treatment by Treatment Type - Percentage
Breakdown of Value Sales for Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy for the Years
2012, 2020 & 2027

ITALY
Table 103: Italy Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 104: Italy Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 105: Italy 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 106: Italy Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 107: Italy Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 108: Italy 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 109: Italy Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 110: Italy Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 111: Italy 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 112: UK Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 113: UK Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 114: UK 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 115: UK Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 116: UK Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 117: UK 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 118: UK Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 119: UK Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 120: UK 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2020 & 2027

SPAIN
Table 121: Spain Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027

Table 122: Spain Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 123: Spain 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2020 & 2027

Table 124: Spain Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 125: Spain Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 126: Spain 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2020 & 2027

Table 127: Spain Current & Future Analysis for Brain Tumor
Diagnosis and Treatment by Treatment Type - Surgery, Radiation
Therapy, Targeted Therapy, Chemotherapy and Immunotherapy -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 128: Spain Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05960584/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001